ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,764Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 46

$1.73M Total Retail Price of All Prescriptions

Rank: 2 out of 46

856 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 856 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

26% of this provider’s 856 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 28,813 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 1,333 1,198 1 4
HYDROCODONE-ACETAMINOPHEN 1,144 989 S3 2 1
FUROSEMIDE 1,050 970 3 7
WARFARIN SODIUM 972 908 4 13
OMEPRAZOLE 874 827 5 5
SIMVASTATIN 815 723 6 6
LISINOPRIL 731 670 7 3
AMLODIPINE BESYLATE 728 656 8 8
DONEPEZIL HCL 639 639 9 19
METOPROLOL TARTRATE 635 562 10 10
NAMENDA 597 581 11 24
GABAPENTIN 555 479 12 11
POTASSIUM CHLORIDE 504 469 13 15
SERTRALINE HCL 467 380 14 22
ATORVASTATIN CALCIUM 406 376 15 20
CITALOPRAM HBR 384 371 16 23
ATENOLOL 383 343 17 18
LEVOFLOXACIN 369 338 18 62
HYDROCHLOROTHIAZIDE 344 299 19 14
METFORMIN HCL 319 280 20 9
FENTANYL 318 288 S2 21 33
TRAMADOL HCL 315 271 22 16
TORSEMIDE 308 255 23 103
ENALAPRIL MALEATE 290 235 24 85
RANITIDINE HCL 283 255 25 26
POLYETHYLENE GLYCOL 3350 278 254 26 34
ESCITALOPRAM OXALATE 273 237 27 49
LANTUS 273 244 27 35
AZITHROMYCIN 271 241 29 30
MIRTAZAPINE 267 240 30 66
RISPERIDONE 267 249 30 54
ALENDRONATE SODIUM 247 231 32 28
QUETIAPINE FUMARATE 243 211 33 61
ZOLPIDEM TARTRATE 231 167 34 21
FLUTICASONE PROPIONATE 230 197 35 72
CARVEDILOL 225 214 36 29
ALLOPURINOL 218 201 37 40
METOPROLOL SUCCINATE 217 180 38 17
TAMSULOSIN HCL 209 159 39 25
TRAZODONE HCL 208 170 40 57
CLOTRIMAZOLE-BETAMETHASONE 202 179 41 125
SPIRONOLACTONE 201 181 42 67
LOSARTAN POTASSIUM 197 184 43 31
CEPHALEXIN 188 166 44 38
CLOPIDOGREL 181 170 45 48
BISOPROLOL-HYDROCHLOROTHIAZIDE 174 138 46 138
MUPIROCIN 167 140 47 100
CYMBALTA 165 130 48 32
NITROFURANTOIN MONO-MACRO 165 156 48 116
NEXIUM 162 132 50 39
CRESTOR 160 156 51 42
DIVALPROEX SODIUM 158 134 52 71
FLUOXETINE HCL 155 138 53 50
GLIPIZIDE 153 148 54 70
PRAVASTATIN SODIUM 152 132 55 12
NOVOLOG 144 120 56 81
PANTOPRAZOLE SODIUM 141 73 57 52
ROPINIROLE HCL 133 122 58 69
OLANZAPINE 131 129 59 83
CIPROFLOXACIN HCL 130 114 60 46
CYCLOBENZAPRINE HCL 130 87 R 60 43
EVISTA 125 113 62 154
ALBUTEROL SULFATE 125 110 62 109
PROMETHAZINE HCL 124 81 R 64 40
LIDODERM 122 119 65 138
FENOFIBRATE 121 96 66 74
GLYBURIDE-METFORMIN HCL 121 95 R 66 159
BUSPIRONE HCL 118 93 68 115
HYDROCORTISONE 117 108 69 163
HUMALOG 117 111 69 137
PLAVIX 116 108 71 75
EXELON 116 116 71 88
AMOX TR-POTASSIUM CLAVULANATE 115 101 73 138
LANSOPRAZOLE 113 96 74 165
PROAIR HFA 112 72 75 45
TRICOR 109 90 76 104
KLOR-CON M20 109 103 76 58
TRILIPIX 107 100 78 166
LOVASTATIN 104 79 79 53
ADVAIR DISKUS 101 87 80 60
OXYBUTYNIN CHLORIDE 101 89 80 79
NITROGLYCERIN PATCH 100 88 82 168
DIOVAN 99 97 83 77
TRIAMTERENE-HCTZ 97 81 84 64
LEVETIRACETAM 96 61 85 82
PAROXETINE HCL 96 75 85 65
OXYBUTYNIN CHLORIDE ER 96 95 85 111
ISOSORBIDE MONONITRATE ER 95 94 88 47
MELOXICAM 95 89 88 43
SPIRIVA 93 89 90 68
LEXAPRO 93 87 90 120
NYSTATIN 91 84 92 84
IPRATROPIUM BROMIDE 85 82 93 171
PREDNISONE 82 76 94 51
ABILIFY 80 78 95 142
NASONEX 80 65 95 173
AMIODARONE HCL 77 71 97 174
NYSTOP 77 62 97 174
DILTIAZEM ER 76 76 99 176
CLONIDINE HCL 76 62 99 99
SEROQUEL 75 53 101 128
DOXYCYCLINE HYCLATE 74 70 102 101
LIPITOR 72 67 103 105
DIGOXIN 71 67 104 80
SULFAMETHOXAZOLE-TRIMETHOPRIM 71 60 104 95
AGGRENOX 69 57 106 181
ETODOLAC 69 65 106 181
HYDROXYZINE HCL 69 55 R 106 114
CARBIDOPA-LEVODOPA 68 68 109 90
LOSARTAN-HYDROCHLOROTHIAZIDE 68 65 109 73
ZETIA 67 55 111 86
KLOR-CON M10 65 55 112 132
PHENYTOIN SODIUM EXTENDED 64 64 113 118
CARISOPRODOL 63 34 R 114 59
LANTUS SOLOSTAR 63 57 114 145
OXYCODONE-ACETAMINOPHEN 63 58 S2 114 89
BACLOFEN 62 0 117 127
METOLAZONE 61 48 118 197
ERYTHROMYCIN 58 52 119 203
MEGESTROL ACETATE 58 58 R 119 203
LOPERAMIDE 57 55 121 158
CARBAMAZEPINE 57 30 121 207
SYNTHROID 57 44 121 124
TRIAMCINOLONE ACETONIDE 55 42 124 150
AMITRIPTYLINE HCL 54 40 R 125 101
TRAVATAN Z 54 54 125 213
SANTYL 54 45 125 213
SEROQUEL XR 53 32 128 215
GLIPIZIDE ER 53 43 128 106
HALOPERIDOL 53 47 128 215
LIDOCAINE HCL 53 43 128 215
FAMOTIDINE 53 44 128 56
CEFTRIAXONE 52 43 133 221
SINGULAIR 51 51 134 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.